Archives prostate-cancer

by in
Entry Author Date Location
East Coast Biotech Roundup: Flagship, SQZ, Epizyme, IPOs & More 06/26/15 Boston
At Exelixis, Morrissey Dreams Of Getting the Band Back Together 06/01/15 San Francisco
Armune Bioscience Develops First Cancer-Specific Prostate Test 05/28/15 Detroit
East Coast Biotech Roundup: Bluebird, Sarepta, Synlogic & More 05/22/15 Boston
Madison Vaccines Expands Series A To Advance Prostate Cancer Drugs 03/10/15 Wisconsin
East Coast Biotech Roundup: Varmus, Bristol, Aerie, Aura & More 03/06/15 Boston
Tiger Teams, Dropping Subs, and Biotech’s Elusive Second Strikes 03/03/15 National
Cancer Immunotherapy Companies: Looking Forward and Looking Back 03/02/15 Seattle
Bellicum CEO Reflects on Rise From Baylor to Houston Biotech Darling 02/26/15 Texas
Exosome Dx, Aiming to Commercialize “Liquid Biopsies,” Seeks $25M 01/28/15 Boston
Texas Cancer Center Seeks to Speed Discovery with Applied Research 12/03/14 Texas
MD Anderson Showcases “Moon Shots” Progress in Fight Against Cancer 11/03/14 Texas
Former Dendreon CEO Gold Working on New Cancer Drug Startups 10/13/14 Wisconsin
Tokai Bags $97M For Prostate Cancer Drug in Upsized IPO 09/17/14 Boston
West Coast Biotech Roundup: Mapp Bio, Calico, Alder, VentiRx & More 09/04/14 San Diego
Exelixis Axes 70% of Workforce as Cancer Drug Flops, Shares Routed 09/02/14 San Francisco
Madison Vaccine to be Tested in Combination Prostate Cancer Treatment 08/28/14 Wisconsin
Madison Startup Rides Immunotherapy Wave With Prostate Drug 08/18/14 Wisconsin
East Coast Biotech Roundup: Amicus, Accelerator, Seventh Sense, & More 08/15/14 Boston
Tokai, Chasing the Field in Prostate Cancer, Files For IPO 08/12/14 Boston
With J&J Deals, Aduro’s Cancer Vaccines Have New Chance To Prove Worth 06/18/14 San Francisco
As Its Investors Reap Returns, venBio Aims for a Bigger Second Fund 06/10/14 San Francisco
West Coast Biotech Roundup: Volcano, Twist, Calibr, ARMO, and More 05/29/14 San Francisco
Prostate Cancer Screening: Seduction Of The Innocent 05/28/14 Seattle
OncoGenex Retrenches, and Searches for Answers, After Failed Trial 05/22/14 Seattle
OncoGenex’s Long Wait For Cancer Drug Ends With a Phase 3 Stumble 04/28/14 Seattle
Backed By a Billionaire, Berg Pharma Aims to Speed Drugmaking 04/02/14 Boston
GenSpera’s Targeted “Death Carrot” Toxin in Trials for Two Cancers 03/27/14 Texas
East Coast Biotech Roundup: ImmusanT, NY Disruptors, Tesaro, & More 03/14/14 Boston
Drug Development 101: A Story About OncoGenex and the FDA 02/26/14 Seattle
Page 1 of 8 next page »